Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
A 2025 pilot study infused up to 20 mg of BPC157 intravenously in 2 healthy adults and reported no adverse effects and no abnormal changes in heart, liver, kidney, thyroid, or bloodglucose markers
SLC25A10) [57]
It contains tirzepatide, which acts on both GLP-1 and GIP receptors
The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways
found that tirzepatide reduced body weight by over 20% and tumor weight by more than 60% in endometrial cancer models, showcasing its dual-action potential against obesity and cancer (Gynecologic Oncology, 2024)
US$ 29.60
US$ 21.26
US$ 24.02
